Farnesol suppresses hypoxia associated EMT signaling and impairs 3D spheroid integrity in A549 lung adenocarcinoma cells
Medical Oncology · 2026
DOI: 10.1007/s12032-026-03372-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Muthuvenugopal Nagakanni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Alagappa University, Karaikudi, India. Hauptthemen laut MEDLINE: Farnesol, Lung Neoplasms, Spheroids, Cellular, Epithelial-Mesenchymal Transition. Die Arbeit nennt 40 Literaturangaben. Gefördert von: RUSA 2.0 [Policy (TNMulti-Gen), Dept of Edn, GoI], CMRG (Government of Tamil Nadu).
Abstract (Originalsprache)
Scratch and Matrigel-assisted transwell assays confirmed that farnesol suppressed the migration and invasion of A549 cells at 21.5 µg/mL. Farnesol inhibited the angiogenic potential of A549 cells via suppression of VEGF. Farnesol reduced the diameter, disrupted the morphology, and induced apoptosis in 3D A549 spheroids. Lung cancer remains the leading cause of high cancer incidence and mortality worldwide. Among lung cancers, non-small cell lung cancer (NSCLC) is the predominant subtype accounting for majority of cancer deaths. The invasive and metastatic behavior of NSCLC largely contributes to its aggressive nature and therapeutic resistance. Farnesol (FAR), a naturally occurring sesquiterpene, has shown anticancer activity in several malignancies however, its mechanistic role in NSCLC invasion and metastasis remains not fully understood. In the present study, we investigated the effect of farnesol on A549 lung adenocarcinoma cells through in vitro approaches involving protein–protein/gene interactions, molecular analysis and 3D screening. Scratch assay and transwell invasion assays were performed to evaluate the effect of farnesol on A549 cell migration and invasion. Immunofluorescence staining analysis were employed to assess the anti-angiogenic potential of farnesol followed by western blotting and real-time PCR to validate the efficacy of farnesol in regulating invasion and metastasis associated markers. Farnesol significantly reduced the viability of A549 cells in a dose-dependent manner, with an IC₅₀ of 21.5 µg/mL inducing cell shrinkage and loss of cell density. Scratch and matrix-assisted transwell invasion assays demonstrated marked inhibition of migration and invasion with increased nonmigratory spaces in farnesol-treated group compared to control. Molecular analysis confirmed upregulation of E-cadherin, downregulation of VEGF, PCAF, COX2, and suppression of mesenchymal and matrix remodeling markers. Farnesol reduced spheroid diameter, dissociation of spheroid integrity and induced of apoptosis at concentrations above 125 µg/mL. Collectively, our findings suggest that farnesol potentially inhibits A549 cell migration, invasion and metastasis, highlighting farnesol as an effective therapeutic candidate for the treatment of lung adenocarcinoma. Graphical Abstract Schematic representation of the current study in elucidating the anticancer potential of FAR through 2D and 3D screening. 2D analysis showed FAR reduces A549 cell viability and migration, with molecular analyses confirmed the impact of FAR in the regulation of invasion and metastasis. In 3D spheroid, farnesol suppressed spheroid growth, reduced proliferation, and induced apoptosis. Additionally, farnesol inhibited HIF1A, COX2 and PCAF leading to reduced expression of MMP2/9 activity, VEGF, and ECM degradation preventing cadherin switching, EMT associated angiogenesis, invasion and metastasis. This highlights FARs therapeutic potential in targeting A549 cancer cell invasion and metastasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Alagappa University, Karaikudi, India.
- Department of Biotechnology, Alagappa University, Karaikudi, India. devikasi@yahoo.com.
Förderung
- RUSA 2.0 [Policy (TNMulti-Gen), Dept of Edn, GoI]
- CMRG (Government of Tamil Nadu)
Zitieren
APA
Nagakanni, M., Jafni, S., Soundarya Rani, R. K., Sangita, B., Kailash, B., Srilekha, M. K., Padmesh, S., & Devi, K. P. (2026). Farnesol suppresses hypoxia associated EMT signaling and impairs 3D spheroid integrity in A549 lung adenocarcinoma cells. Medical Oncology. https://doi.org/10.1007/s12032-026-03372-w
Vancouver
Nagakanni M, Jafni S, Soundarya Rani RK, Sangita B, Kailash B, Srilekha MK, et al. Farnesol suppresses hypoxia associated EMT signaling and impairs 3D spheroid integrity in A549 lung adenocarcinoma cells. Medical Oncology. 2026. doi:10.1007/s12032-026-03372-w
BibTeX
@article{Nagakanni2026,
author = {Nagakanni, Muthuvenugopal and Jafni, Sakthivel and Soundarya Rani, Rajendra Kumar and Sangita, Behera and Kailash, Baskaran and Srilekha, Muralidharan Kannan and Padmesh, Sivakumar and Devi, Kasi Pandima},
title = {Farnesol suppresses hypoxia associated EMT signaling and impairs 3D spheroid integrity in A549 lung adenocarcinoma cells},
journal = {Medical Oncology},
year = {2026},
doi = {10.1007/s12032-026-03372-w}
}
EUVIMED